Testing effectiveness (Phase 2)Ended earlyNCT01287338
What this trial is testing
Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Who this might be right for
Seasonal Allergic Conjunctivitis to Ragweed
Mati Therapeutics Inc. 143